Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity. 2002

Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
Departments of Endocrinology and Pediatric Neurology, Medical Academy, Bialystok, Poland; and the Max-Planck-Institute for Experimental Medicine, Goettingen, Germany.

Intercellular adhesion molecule-1 (ICAM-1) is 1 of the possible factors linking obesity and diabetes with cardiovascular disease, however, the mechanism of the increase in ICAM-1 concentration in obesity remains unclear. Therefore, the aim of the present study was to assess plasma soluble ICAM-1 (sICAM-1) levels in obese subjects with normal glucose tolerance and to evaluate whether those levels may be related to insulin resistance and tumor necrosis factor-alpha (TNFalpha) system activity. The study was performed in 8 lean and 15 obese subjects. Anthropometric and biochemical parameters were measured, and insulin sensitivity was evaluated using the euglycemic hyperinsulinemic clamp technique (insulin infusion, 50 mU x kg(-1) x h(-1)). Obese subjects were markedly more hyperinsulinemic and insulin resistant and had higher plasma soluble TNF receptor 2 (sTNFR2) and sICAM-1 levels. sICAM-1 was related positively to body mass index (BMI), waist-to-hip ratio (WHR), percent of body fat, glycated hemoglobin (HbA(1c)), plasma insulin and triglycerides (TG), TNFalpha, and sTNFR2 and negatively to insulin sensitivity. Multiple regression analysis showed that only sTNFR2 and insulin sensitivity were independent predictors of sICAM-1 concentrations and were responsible for 66% of sICAM-1 variability. We conclude that an increase in plasma sICAM-1 concentration in obesity is related to TNFalpha system activation and insulin resistance.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013851 Thinness A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards, such as BODY MASS INDEX, and dependent on age, sex, and genetic background. Leanness,Underweight
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
January 1998, Allergy,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
April 2007, The Journal of rheumatology,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
December 1996, Pediatric AIDS and HIV infection,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
January 1995, Rheumatology international,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
December 2001, Thyroid : official journal of the American Thyroid Association,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
January 2006, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
March 1998, International journal of molecular medicine,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
July 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
January 2002, Journal of investigational allergology & clinical immunology,
Marek Straczkowski, and Piotr Lewczuk, and Stella Dzienis-Straczkowska, and Irina Kowalska, and Agnieszka Stepień, and Ida Kinalska
August 2002, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!